throbber
8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Bausch Lomb Inc
`
`FDA Filings
`This page includes the latest FDA filings for Bausch Lomb Inc. Currently, you
`will find the latest 100 filings for Premarket Notifications, Premarket
`Applications, De Novo Applications, and GUDID registrations.
`
`FDA Registration(s)
`
`Registration Number
`
`1123818
`
`FEI Number
`
`1000305478
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`Y
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`1501 Graves Mill Rd
`
`Lynchburg, VA 24502 US
`
`Establishment Type
`
`Repack or Relabel Medical Device
`Manufacture Medical Device
`
`Registration Number
`
`1281950
`
`FEI Number
`
`1281950
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`N
`
`Registration Expiration 2020-04-25
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`1/37
`
`Eye Therapies Exhibit 2098, 1 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Registration Address
`
`100 RESEARCH DRIVE
`
`WILMINGTON, MA 01887 US
`
`Establishment Type
`
`Develop Specifications But Do Not Manufacture At This Facility
`Manufacture Medical Device
`
`Registration Number
`
`1032500
`
`FEI Number
`
`1032500
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`N
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`8507 PELHAM RD.
`
`GREENVILLE, SC 29615 US
`
`Establishment Type
`
`Manufacture Medical Device
`
`Registration Number
`
`1932180
`
`FEI Number
`
`1000119305
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`Y
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`499 SOVEREIGN CT.
`
`Manchester, MO 63011 US
`
`Establishment Type
`
`Manufacture Medical Device
`Repack or Relabel Medical Device
`Develop Specifications But Do Not Manufacture At This Facility
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`2/37
`
`Eye Therapies Exhibit 2098, 2 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Registration Number
`
`1313525
`
`FEI Number
`
`1317628
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`N
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`1400 North Goodman Street
`Rochester, NY 14609 US
`
`Establishment Type
`
`Complaint File Establishment per 21 CFR 820.198
`Develop Specifications But Do Not Manufacture At This Facility
`
`Registration Number
`
`1920664
`
`FEI Number
`
`1920664
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`Owner & Operator
`
`Bausch Health Companies Inc. (/Company/Bausch-Health-Companies-Inc)
`
`Contact Address
`
`400 Somerset Corporate Blvd. --
`Bridgewater NJ 08807 US
`
`Official Correspondent
`
`Harry Jeffreys
`x-908-5418650-x
`
`Registration Status
`
`Initial Importer
`
`1
`
`Y
`
`Registration Expiration 2020-04-25
`
`Registration Address
`
`3365 TREE CT. INDUSTRIAL BLVD.
`Saint Louis, MO 63122 US
`
`Establishment Type
`
`Manufacture Medical Device
`Develop Specifications But Do Not Manufacture At This Facility
`Repack or Relabel Medical Device
`Remanufacture Medical Device
`
`Registration Number
`
`1119279
`
`FEI Number
`
`1119279
`
`Name
`
`Bausch & Lomb Incorporated (/Company/Bausch-Lomb-Inc)
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`3/37
`
`Eye Therapies Exhibit 2098, 3 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2098, 4 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Alrex (https://fda.report/DailyMed/21c76da0-
`50a1-41c0-91b8-8cc4dcc27f60)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Methazolamide
`(https://fda.report/DailyMed/0c0ba5c7-c53e-
`4e29-a7ff-48fddc5a9258)
`Bausch & Lomb Incorporated, Micro Labs
`Limited
`
`Timolol Maleate
`(https://fda.report/DailyMed/581f80f7-4419-49e2-
`867d-40443c75409f)
`Bausch & Lomb Americas Inc., Bausch & Lomb
`Incorporated, Carton Services, Incorporated
`
`Prolensa (https://fda.report/DailyMed/4e072537-
`f73c-4a96-a65f-e2805ce112d8)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Muro 128 (https://fda.report/DailyMed/454f337e-
`d897-46de-ab05-1c543a33061c)
`Bausch & Lomb Incorporated
`
`Otc Medication
`
`LUMIFY Redness Reliever Eye Drops
`(https://fda.report/DailyMed/022de945-0b26-
`40ae-8e88-d3fe2464d106)
`Bausch & Lomb Incorporated, Laboratoire
`Unither
`
`Eye Itch Releif
`(https://fda.report/DailyMed/6a7be1e9-27ff-44d8-
`85ed-fc1b0017180e)
`Rite Aid Corporation, Bausch & Lomb
`Incorporated
`
`Tetracaine Hydrochloride
`(https://fda.report/DailyMed/807dae5d-f34a-4f3d-
`9f54-dd350b056a92)
`Oceanside Pharmaceuticals, Bausch & Lomb
`Incorporated
`
`Otc Medication
`
`Otc Medication
`
`Prescription Medication
`
`GUDID 00757770571758
`(https://fda.report/GUDID/00757770571758)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb
`
`GUDID 00310119039984
`(https://fda.report/GUDID/00310119039984)
`Bausch & Lomb Incorporated
`
`GUDID 00310119039977
`(https://fda.report/GUDID/00310119039977)
`Bausch & Lomb Incorporated
`
`GUDID 00310119039960
`(https://fda.report/GUDID/00310119039960)
`Bausch & Lomb Incorporated
`
`GUDID 00310119039946
`(https://fda.report/GUDID/00310119039946)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb FCP-4373
`
`Bausch + Lomb FCP-4373
`
`Bausch + Lomb FCP-4373
`
`Bausch + Lomb FCP-4373
`
`GUDID 00757770473946
`(https://fda.report/GUDID/00757770473946)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb
`
`2022-
`05-26
`
`2022-
`05-25
`
`2022-
`05-21
`
`2022-
`05-05
`
`2022-
`04-29
`
`2022-
`04-28
`
`2022-
`04-01
`
`2022-
`03-09
`
`2022-
`03-08
`
`2022-
`03-08
`
`2022-
`03-08
`
`2022-
`03-08
`
`2022-
`03-08
`
`2022-
`03-07
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`5/37
`
`Eye Therapies Exhibit 2098, 5 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Zylet (https://fda.report/DailyMed/3dd9b060-
`5355-404d-bdf1-09ee8b52a9f5)
`Bausch & Lomb Incorporated, Bausch & Lomb
`Incoporated
`
`Bausch Lomb Inc FDA Filings
`
`Prescription Medication
`
`Timoptic (https://fda.report/DailyMed/45ac65b3-
`19f7-4f33-aebf-cadd3daa4bf1)
`Bausch & Lomb Incorporated
`
`GUDID 00757770059881
`(https://fda.report/GUDID/00757770059881)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Bausch + Lomb IVC-21
`
`PMA P910056S049
`(https://fda.report/PMA/P910056S049)
`Bausch & Lomb, Inc.
`
`enVista® Hydrophobic Acrylic
`Intraocular Lens (IOL)
`
`PMA P060022S029
`(https://fda.report/PMA/P060022S029)
`Bausch & Lomb, Inc.
`
`Akreos® Posterior Chamber
`Intraocular Lens (IOL)
`
`PMA P030002S040
`(https://fda.report/PMA/P030002S040)
`Bausch & Lomb, Inc.
`
`Crystalens Accommodating Posterior
`Chamber & Trulign Toric Intraocular
`Lenses (IOL)
`
`PMA P980006S033
`(https://fda.report/PMA/P980006S033)
`Bausch & Lomb, Inc.
`
`Bausch+ Lomb Pure Vision®
`(balafilcon A) Visibility Tinted Soft
`Contact Lenses
`
`PMA P170035S015
`(https://fda.report/PMA/P170035S015)
`Bausch And Lomb, Inc.
`
`Bausch+ Lomb Ultra (samfilcon A)
`Visibility Tinted Soft (hydrophillic)
`Contact Lenses
`
`NDC 24208-040 (https://fda.report/NDC/24208-
`040)
`
`Xipere
`
`Bausch & Lomb Incorporated
`
`Muro 128 (https://fda.report/DailyMed/454f337e-
`d897-46de-ab05-1c543a33061c)
`Bausch & Lomb Incorporated
`
`Otc Medication
`
`Latanoprost
`(https://fda.report/DailyMed/68aaacbe-98c5-
`450b-9bf4-4809d7ad2ca0)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`PMN K211786 (https://fda.report/PMN/K211786)
`Bausch + Lomb, Incorporated
`
`Independent Corneal Viewing
`Chamber (IVC-21)
`
`Timoptic (https://fda.report/DailyMed/45ac65b3-
`19f7-4f33-aebf-cadd3daa4bf1)
`Bausch & Lomb Incorporated
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/806ad1b6-0de7-
`4e9a-be86-475c0ef2c340)
`Target Corporation, Bausch & Lomb Incorporated
`
`Sodium Chloride Hypertonicity Ophthalmic
`(https://fda.report/DailyMed/7546770d-bc12-
`44b8-9fe0-fc3f5e1d12d1)
`Rugby Laboratories, Bausch & Lomb
`Incorporated
`
`Prescription Medication
`
`Otc Medication
`
`Otc Medication
`
`2022-
`03-01
`
`2022-
`02-23
`
`2022-
`02-14
`
`2022-
`01-19
`
`2022-
`01-19
`
`2022-
`01-19
`
`2022-
`01-13
`
`2022-
`01-13
`
`2021-
`12-17
`
`2021-
`12-17
`
`2021-
`12-09
`
`2021-
`12-03
`
`2021-
`12-01
`
`2021-11-
`23
`
`2021-11-
`23
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`6/37
`
`Eye Therapies Exhibit 2098, 6 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Otc Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Artificial Tears Lubricant Eye Drops
`(https://fda.report/DailyMed/28297fee-8185-
`4869-8f39-5bfbf8bf8bfd)
`CVS Pharmacy, Bausch & Lomb Incorporate,
`Bausch & Lomb Incorporated
`
`Zylet (https://fda.report/DailyMed/3dd9b060-
`5355-404d-bdf1-09ee8b52a9f5)
`Bausch & Lomb Incorporated, Bausch & Lomb
`Incoporated
`
`Flunisolide
`(https://fda.report/DailyMed/7c72c954-3758-
`40c3-9977-d03b25d71e0a)
`Bausch & Lomb Incorporated, Bausch Health
`Companies Inc.
`
`GUDID 00757770520022
`(https://fda.report/GUDID/00757770520022)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb EZ-28V
`
`GUDID 00757770505326
`(https://fda.report/GUDID/00757770505326)
`Bausch & Lomb Incorporated
`
`Bausch + Lomb
`
`PMA P910056S048
`(https://fda.report/PMA/P910056S048)
`Bausch & Lomb, Inc.
`
`enVista® hydrophobic acrylic
`intraocular lens (IOL)
`
`Eye Wash (https://fda.report/DailyMed/1e742f99-
`0b29-4877-80f3-0bbe1a3207f1)
`Rite Aid Corporation, Bausch & Lomb
`Incorporated
`
`Otc Medication
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/6043040e-3206-
`40dd-aa87-940b1a84a496)
`Rite Aid Corporation, Bausch & Lomb
`Incorporated, Loba Feinchemie AG
`
`Latanoprost
`(https://fda.report/DailyMed/68aaacbe-98c5-
`450b-9bf4-4809d7ad2ca0)
`Bausch & Lomb Incorporated
`
`Otc Medication
`
`Prescription Medication
`
`PMA P980006S032
`(https://fda.report/PMA/P980006S032)
`Bausch & Lomb, Inc.
`
`PureVision (balafilcon A) Contact
`Lens
`
`PMA P810025S043
`(https://fda.report/PMA/P810025S043)
`Bausch & Lomb, Inc.
`
`Amvisc Ophthalmic Viscosurgical ,
`Amvisc Plus Ophthalmic
`Viscosurgical (OVD)
`
`PMA P170035S013
`(https://fda.report/PMA/P170035S013)
`Bausch And Lomb, Inc.
`
`Rugby Eye Wash
`(https://fda.report/DailyMed/1fee974b-4c29-
`4965-bd3d-da5e219eb13a)
`Rugby Laboratories, KC Pharmaceuticals, Inc.,
`Bausch & Lomb Incorporated, KC
`Pharmaceuticals
`
`Ultra (samfilcon A) Contact Lens
`
`Otc Medication
`
`2021-11-
`23
`
`2021-11-
`09
`
`2021-11-
`03
`
`2021-
`10-29
`
`2021-
`10-29
`
`2021-
`10-14
`
`2021-
`10-05
`
`2021-
`10-01
`
`2021-
`09-15
`
`2021-
`08-27
`
`2021-
`08-27
`
`2021-
`08-27
`
`2021-
`07-31
`
`PMA P910056S046
`(https://fda.report/PMA/P910056S046)
`Bausch & Lomb, Inc.
`
`enVista Hydrophobic Acrylic
`Intraocular Lens (IOL)
`
`2021-
`07-21
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`7/37
`
`Eye Therapies Exhibit 2098, 7 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Prescription Medication
`
`Erythromycin
`(https://fda.report/DailyMed/061ddd20-94a6-
`4e3c-ba84-1ebd8529eea6)
`Bausch & Lomb Incorporated, Bausch & Lomb,
`Inc.
`
`Prescription Medication
`
`2021-
`07-17
`
`2021-
`07-13
`
`Istalol (https://fda.report/DailyMed/258bbc8d-
`00ee-45b0-ac35-6f16c4e8d45f)
`Bausch & Lomb Incorporated
`
`PMA P810025S042
`(https://fda.report/PMA/P810025S042)
`Bausch & Lomb, Inc.
`
`GUDID 10757770144096
`(https://fda.report/GUDID/10757770144096)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144089
`(https://fda.report/GUDID/10757770144089)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144072
`(https://fda.report/GUDID/10757770144072)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144065
`(https://fda.report/GUDID/10757770144065)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144058
`(https://fda.report/GUDID/10757770144058)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144041
`(https://fda.report/GUDID/10757770144041)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144034
`(https://fda.report/GUDID/10757770144034)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144027
`(https://fda.report/GUDID/10757770144027)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144010
`(https://fda.report/GUDID/10757770144010)
`Bausch & Lomb Incorporated
`
`GUDID 10757770144003
`(https://fda.report/GUDID/10757770144003)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143990
`(https://fda.report/GUDID/10757770143990)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143983
`(https://fda.report/GUDID/10757770143983)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143976
`(https://fda.report/GUDID/10757770143976)
`Bausch & Lomb Incorporated
`
`Amvisc and Amvisc Plus Ophthalmic
`Viscosurgical (OVD)
`
`2021-
`07-08
`
`EZE-fit PMMA IOL EZE-60 8A215
`
`EZE-fit PMMA IOL EZE-60 8A210
`
`EZE-fit PMMA IOL EZE-60 8A205
`
`EZE-fit PMMA IOL EZE-60 8A200
`
`EZE-fit PMMA IOL EZE-60 8A195
`
`EZE-fit PMMA IOL EZE-60 8A190
`
`EZE-fit PMMA IOL EZE-60 8A185
`
`EZE-fit PMMA IOL EZE-60 8A180
`
`EZE-fit PMMA IOL EZE-60 8A175
`
`EZE-fit PMMA IOL EZE-60 8A170
`
`EZE-fit PMMA IOL EZE-60 8A165
`
`EZE-fit PMMA IOL EZE-60 8A160
`
`EZE-fit PMMA IOL EZE-60 8A155
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`8/37
`
`Eye Therapies Exhibit 2098, 8 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770143969
`(https://fda.report/GUDID/10757770143969)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143952
`(https://fda.report/GUDID/10757770143952)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143945
`(https://fda.report/GUDID/10757770143945)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143938
`(https://fda.report/GUDID/10757770143938)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143921
`(https://fda.report/GUDID/10757770143921)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143914
`(https://fda.report/GUDID/10757770143914)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143907
`(https://fda.report/GUDID/10757770143907)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143891
`(https://fda.report/GUDID/10757770143891)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143884
`(https://fda.report/GUDID/10757770143884)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143877
`(https://fda.report/GUDID/10757770143877)
`Bausch & Lomb Incorporated
`
`GUDID 10757770143860
`(https://fda.report/GUDID/10757770143860)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097644
`(https://fda.report/GUDID/10757770097644)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097620
`(https://fda.report/GUDID/10757770097620)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097606
`(https://fda.report/GUDID/10757770097606)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097583
`(https://fda.report/GUDID/10757770097583)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097569
`(https://fda.report/GUDID/10757770097569)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097545
`(https://fda.report/GUDID/10757770097545)
`Bausch & Lomb Incorporated
`
`EZE-fit PMMA IOL EZE-60 8A150
`
`EZE-fit PMMA IOL EZE-60 8A145
`
`EZE-fit PMMA IOL EZE-60 8A140
`
`EZE-fit PMMA IOL EZE-60 8A135
`
`EZE-fit PMMA IOL EZE-60 8A130
`
`EZE-fit PMMA IOL EZE-60 8A125
`
`EZE-fit PMMA IOL EZE-60 8A120
`
`EZE-fit PMMA IOL EZE-60 8A115
`
`EZE-fit PMMA IOL EZE-60 8A110
`
`EZE-fit PMMA IOL EZE-60 8A105
`
`EZE-fit PMMA IOL EZE-60 8A100
`
`EZE-fit PMMA IOL P359UV 2R450
`
`EZE-fit PMMA IOL P359UV 2R440
`
`EZE-fit PMMA IOL P359UV 2R430
`
`EZE-fit PMMA IOL P359UV 2R420
`
`EZE-fit PMMA IOL P359UV 2R410
`
`EZE-fit PMMA IOL P359UV 2R400
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`9/37
`
`Eye Therapies Exhibit 2098, 9 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770097521
`(https://fda.report/GUDID/10757770097521)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097507
`(https://fda.report/GUDID/10757770097507)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097484
`(https://fda.report/GUDID/10757770097484)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097460
`(https://fda.report/GUDID/10757770097460)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097446
`(https://fda.report/GUDID/10757770097446)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097422
`(https://fda.report/GUDID/10757770097422)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097408
`(https://fda.report/GUDID/10757770097408)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097385
`(https://fda.report/GUDID/10757770097385)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097361
`(https://fda.report/GUDID/10757770097361)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097347
`(https://fda.report/GUDID/10757770097347)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097330
`(https://fda.report/GUDID/10757770097330)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097323
`(https://fda.report/GUDID/10757770097323)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097316
`(https://fda.report/GUDID/10757770097316)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097309
`(https://fda.report/GUDID/10757770097309)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097293
`(https://fda.report/GUDID/10757770097293)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097286
`(https://fda.report/GUDID/10757770097286)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097279
`(https://fda.report/GUDID/10757770097279)
`Bausch & Lomb Incorporated
`
`EZE-fit PMMA IOL P359UV 2R390
`
`EZE-fit PMMA IOL P359UV 2R380
`
`EZE-fit PMMA IOL P359UV 2R370
`
`EZE-fit PMMA IOL P359UV 2R360
`
`EZE-fit PMMA IOL P359UV 2R350
`
`EZE-fit PMMA IOL P359UV 2R340
`
`EZE-fit PMMA IOL P359UV 2R330
`
`EZE-fit PMMA IOL P359UV 2R320
`
`EZE-fit PMMA IOL P359UV 2R310
`
`EZE-fit PMMA IOL P359UV 2R300
`
`EZE-fit PMMA IOL P359UV 2R295
`
`EZE-fit PMMA IOL P359UV 2R290
`
`EZE-fit PMMA IOL P359UV 2R285
`
`EZE-fit PMMA IOL P359UV 2R280
`
`EZE-fit PMMA IOL P359UV 2R275
`
`EZE-fit PMMA IOL P359UV 2R270
`
`EZE-fit PMMA IOL P359UV 2R265
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`10/37
`
`Eye Therapies Exhibit 2098, 10 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770097262
`(https://fda.report/GUDID/10757770097262)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097255
`(https://fda.report/GUDID/10757770097255)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097248
`(https://fda.report/GUDID/10757770097248)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097231
`(https://fda.report/GUDID/10757770097231)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097224
`(https://fda.report/GUDID/10757770097224)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097217
`(https://fda.report/GUDID/10757770097217)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097200
`(https://fda.report/GUDID/10757770097200)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097194
`(https://fda.report/GUDID/10757770097194)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097187
`(https://fda.report/GUDID/10757770097187)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097170
`(https://fda.report/GUDID/10757770097170)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097163
`(https://fda.report/GUDID/10757770097163)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097156
`(https://fda.report/GUDID/10757770097156)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097149
`(https://fda.report/GUDID/10757770097149)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097132
`(https://fda.report/GUDID/10757770097132)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097125
`(https://fda.report/GUDID/10757770097125)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097118
`(https://fda.report/GUDID/10757770097118)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097101
`(https://fda.report/GUDID/10757770097101)
`Bausch & Lomb Incorporated
`
`EZE-fit PMMA IOL P359UV 2R260
`
`EZE-fit PMMA IOL P359UV 2R255
`
`EZE-fit PMMA IOL P359UV 2R250
`
`EZE-fit PMMA IOL P359UV 2R245
`
`EZE-fit PMMA IOL P359UV 2R240
`
`EZE-fit PMMA IOL P359UV 2R235
`
`EZE-fit PMMA IOL P359UV 2R230
`
`EZE-fit PMMA IOL P359UV 2R225
`
`EZE-fit PMMA IOL P359UV 2R220
`
`EZE-fit PMMA IOL P359UV 2R215
`
`EZE-fit PMMA IOL P359UV 2R210
`
`EZE-fit PMMA IOL P359UV 2R205
`
`EZE-fit PMMA IOL P359UV 2R200
`
`EZE-fit PMMA IOL P359UV 2R195
`
`EZE-fit PMMA IOL P359UV 2R190
`
`EZE-fit PMMA IOL P359UV 2R185
`
`EZE-fit PMMA IOL P359UV 2R180
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`11/37
`
`Eye Therapies Exhibit 2098, 11 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770097095
`(https://fda.report/GUDID/10757770097095)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097088
`(https://fda.report/GUDID/10757770097088)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097071
`(https://fda.report/GUDID/10757770097071)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097064
`(https://fda.report/GUDID/10757770097064)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097057
`(https://fda.report/GUDID/10757770097057)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097040
`(https://fda.report/GUDID/10757770097040)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097033
`(https://fda.report/GUDID/10757770097033)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097026
`(https://fda.report/GUDID/10757770097026)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097019
`(https://fda.report/GUDID/10757770097019)
`Bausch & Lomb Incorporated
`
`GUDID 10757770097002
`(https://fda.report/GUDID/10757770097002)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096999
`(https://fda.report/GUDID/10757770096999)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096982
`(https://fda.report/GUDID/10757770096982)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096975
`(https://fda.report/GUDID/10757770096975)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096968
`(https://fda.report/GUDID/10757770096968)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096951
`(https://fda.report/GUDID/10757770096951)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096944
`(https://fda.report/GUDID/10757770096944)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096920
`(https://fda.report/GUDID/10757770096920)
`Bausch & Lomb Incorporated
`
`EZE-fit PMMA IOL P359UV 2R175
`
`EZE-fit PMMA IOL P359UV 2R170
`
`EZE-fit PMMA IOL P359UV 2R165
`
`EZE-fit PMMA IOL P359UV 2R160
`
`EZE-fit PMMA IOL P359UV 2R155
`
`EZE-fit PMMA IOL P359UV 2R150
`
`EZE-fit PMMA IOL P359UV 2R145
`
`EZE-fit PMMA IOL P359UV 2R140
`
`EZE-fit PMMA IOL P359UV 2R135
`
`EZE-fit PMMA IOL P359UV 2R130
`
`EZE-fit PMMA IOL P359UV 2R125
`
`EZE-fit PMMA IOL P359UV 2R120
`
`EZE-fit PMMA IOL P359UV 2R115
`
`EZE-fit PMMA IOL P359UV 2R110
`
`EZE-fit PMMA IOL P359UV 2R105
`
`EZE-fit PMMA IOL P359UV 2R100
`
`EZE-fit PMMA IOL P359UV 2R090
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`12/37
`
`Eye Therapies Exhibit 2098, 12 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`GUDID 10757770096906
`(https://fda.report/GUDID/10757770096906)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096883
`(https://fda.report/GUDID/10757770096883)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096869
`(https://fda.report/GUDID/10757770096869)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096845
`(https://fda.report/GUDID/10757770096845)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096821
`(https://fda.report/GUDID/10757770096821)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096807
`(https://fda.report/GUDID/10757770096807)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096784
`(https://fda.report/GUDID/10757770096784)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096760
`(https://fda.report/GUDID/10757770096760)
`Bausch & Lomb Incorporated
`
`GUDID 10757770096746
`(https://fda.report/GUDID/10757770096746)
`Bausch & Lomb Incorporated
`
`Dorzolamide Hydrochloride and Timolol Maleate
`(https://fda.report/DailyMed/7f6ab3f6-3644-434c-
`b6cf-e4f111d18962)
`
`Bausch & Lomb Incorporated
`
`LUMIFY Redness Reliever Eye Drops
`(https://fda.report/DailyMed/022de945-0b26-
`40ae-8e88-d3fe2464d106)
`Bausch & Lomb Incorporated, Laboratoire
`Unither
`
`Ipratropium bromide
`(https://fda.report/DailyMed/1e92b86d-66e1-
`45e4-9e23-f9310c95bf82)
`Bausch & Lomb Incorporated
`
`Loteprednol Etabonate
`(https://fda.report/DailyMed/7bbdbd31-5a8f-
`4d69-aa8e-5b700895e804)
`Bausch & Lomb Incorporated
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/6043040e-3206-
`40dd-aa87-940b1a84a496)
`Rite Aid Corporation, Bausch & Lomb
`Incorporated, Loba Feinchemie AG
`
`Ipratropium Bromide
`(https://fda.report/DailyMed/3fd850a2-af0f-4291-
`af5d-52c8d6094e64)
`Bausch & Lomb Incorporated, Bausch Health
`Companies Inc.
`
`EZE-fit PMMA IOL P359UV 2R080
`
`EZE-fit PMMA IOL P359UV 2R070
`
`EZE-fit PMMA IOL P359UV 2R060
`
`EZE-fit PMMA IOL P359UV 2R050
`
`EZE-fit PMMA IOL P359UV 2R040
`
`EZE-fit PMMA IOL P359UV 2R030
`
`EZE-fit PMMA IOL P359UV 2R020
`
`EZE-fit PMMA IOL P359UV 2R010
`
`EZE-fit PMMA IOL P359UV 2R000
`
`Prescription Medication
`
`Otc Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Otc Medication
`
`Prescription Medication
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-08
`
`2021-
`07-07
`
`2021-
`07-07
`
`2021-
`06-17
`
`2021-
`06-16
`
`2021-
`06-11
`
`2021-
`06-11
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`13/37
`
`Eye Therapies Exhibit 2098, 13 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2098, 14 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Prescription Medication
`
`Timolol Maleate
`(https://fda.report/DailyMed/0c488889-6c37-
`44a2-94e2-97f98d48d6fb)
`BAUSCH & LOMB INCORPORATED,
`Laboratoire Unither
`
`Latanoprost
`(https://fda.report/DailyMed/68aaacbe-98c5-
`450b-9bf4-4809d7ad2ca0)
`Bausch & Lomb Incorporated
`
`EYE ALLERGY RELIEF
`(https://fda.report/DailyMed/253130b4-a23b-
`43a0-b125-0fa5bd01b2b6)
`CVS PHARMACY, Bausch & Lomb Incorporated
`
`Retisert (https://fda.report/DailyMed/1ab0f849-
`2a0d-47ce-ad05-768094da8cc9)
`Bausch & Lomb Incorporated, Bausch and Lomb
`Ireland Limited, Carton Service Inc.
`
`Loteprednol Etabonate
`(https://fda.report/DailyMed/7bbdbd31-5a8f-
`4d69-aa8e-5b700895e804)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Otc Medication
`
`Prescription Medication
`
`Prescription Medication
`
`PMA P860047S034
`(https://fda.report/PMA/P860047S034)
`Bausch & Lomb, Inc.
`
`OcuCoat OVD
`
`Prescription Medication
`
`Latanoprost
`(https://fda.report/DailyMed/68aaacbe-98c5-
`450b-9bf4-4809d7ad2ca0)
`Bausch & Lomb Incorporated
`
`PMA P910056S044
`(https://fda.report/PMA/P910056S044)
`Bausch & Lomb, Inc.
`
`2021-
`03-18
`
`2021-
`03-11
`
`2021-
`03-05
`
`2021-
`03-05
`
`2021-
`02-18
`
`2021-
`01-13
`
`2021-
`01-06
`
`enVista One-Piece Foldable Acrylic
`Intraocular Lens
`
`2020-
`12-21
`
`PMA P060022S028
`(https://fda.report/PMA/P060022S028)
`Bausch & Lomb, Inc.
`
`Akreos One-Piece Foldable Acrylic
`Intraocular Lens
`
`LUMIFY Redness Reliever Eye Drops
`(https://fda.report/DailyMed/022de945-0b26-
`40ae-8e88-d3fe2464d106)
`Bausch & Lomb Incorporated, Laboratoire
`Unither
`
`Otc Medication
`
`Eye Itch Relief
`(https://fda.report/DailyMed/7d0146a9-5073-
`4e24-954f-75b84affadc2)
`CVS Pharmacy, Bausch & Lomb Incorporated
`
`Otc Medication
`
`Cromolyn Sodium
`(https://fda.report/DailyMed/379f4b59-6866-
`4b5c-9b1b-d8a35b741461)
`Bausch & Lomb Incorporated, Cambrex
`Profarmaco Milano Srl, Aventis Pharma
`Manufacturing Pte LTD.
`
`Otc Medication
`
`Eye Wash
`(https://fda.report/DailyMed/354402ad-581d-
`47e7-9fd3-933bef281ff4)
`Kroger Company, Bausch & Lomb Incorporated
`
`Otc Medication
`
`2020-
`12-21
`
`2020-
`12-18
`
`2020-
`12-16
`
`2020-
`12-10
`
`2020-
`12-09
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`15/37
`
`Eye Therapies Exhibit 2098, 15 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`Tobramycin and Dexamethasone
`(https://fda.report/DailyMed/33de419e-a89b-
`47e5-952b-87e837f5d531)
`Bausch & Lomb Incorporated
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/806ad1b6-0de7-
`4e9a-be86-475c0ef2c340)
`Target Corporation, Bausch & Lomb Incorporated
`
`Dorzolamide Hydrochloride and Timolol Maleate
`(https://fda.report/DailyMed/7f6ab3f6-3644-434c-
`b6cf-e4f111d18962)
`
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Otc Medication
`
`Prescription Medication
`
`PMA P170035S011
`(https://fda.report/PMA/P170035S011)
`Bausch And Lomb, Inc.
`
`Bausch + Lomb Ultra (samfilcon A)
`Visibility Tinted Soft (hydrophilic)
`Contact Lenses
`
`Sodium Chloride Hypertonicity Ophthalmic
`(https://fda.report/DailyMed/7546770d-bc12-
`44b8-9fe0-fc3f5e1d12d1)
`Rugby Laboratories, Bausch & Lomb
`Incorporated
`
`Otc Medication
`
`Eye Wash
`(https://fda.report/DailyMed/354402ad-581d-
`47e7-9fd3-933bef281ff4)
`Kroger Company, Bausch & Lomb Incorporated
`
`Otc Medication
`
`LUMIFY Redness Reliever Eye Drops
`(https://fda.report/DailyMed/022de945-0b26-
`40ae-8e88-d3fe2464d106)
`Bausch & Lomb Incorporated, Laboratoire
`Unither
`
`Otc Medication
`
`PMA P170035S010
`(https://fda.report/PMA/P170035S010)
`Bausch And Lomb, Inc.
`
`Bausch + Lomb Ultra (samfilcon A)
`Visibility Tinted Soft (hydrophilic)
`Contact Lenses
`
`Macugen (https://fda.report/DailyMed/45d03177-
`5d52-492c-b2e0-01afc7c8d2e0)
`Bausch & Lomb Incorporated, Pfizer
`Manufacturing Belgium NV
`
`Prolensa (https://fda.report/DailyMed/4e072537-
`f73c-4a96-a65f-e2805ce112d8)
`Bausch & Lomb Incorporated
`
`Prescription Medication
`
`Prescription Medication
`
`NDC 24208-023 (https://fda.report/NDC/24208-
`023)
`
`Bausch & Lomb Incorporated
`
`Methazolamide
`
`NDC 24208-022 (https://fda.report/NDC/24208-
`022)
`
`Bausch & Lomb Incorporated
`
`Methazolamide
`
`2020-
`12-09
`
`2020-
`12-08
`
`2020-
`12-05
`
`2020-11-
`19
`
`2020-11-
`19
`
`2020-11-
`07
`
`2020-
`10-29
`
`2020-
`10-19
`
`2020-
`10-15
`
`2020-
`10-10
`
`2020-
`10-02
`
`2020-
`10-02
`
`PMA P810025S040
`(https://fda.report/PMA/P810025S040)
`Bausch & Lomb, Inc.
`
`Amvisc and Amvisc Plus Ophthalmic
`Viscosurgical (OVD)
`
`2020-
`10-01
`
`PMA P980006S030
`(https://fda.report/PMA/P980006S030)
`Bausch & Lomb, Inc.
`
`Bausch + Lomb PureVision
`(balafilcon A) Visibility Tinted Soft
`(hydrophilic) Contact Lenses
`
`PMA P170035S009
`(https://fda.report/PMA/P170035S009)
`Bausch And Lomb, Inc.
`
`Bausch + Lomb Ultra (samfilcon A)
`Visibility Tinted Soft (hydrophilic)
`Contact Lenses
`
`2020-
`09-28
`
`2020-
`09-28
`
`https://fda.report/Company/Bausch-Lomb-Inc
`
`16/37
`
`Eye Therapies Exhibit 2098, 16 of 37
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`8/15/22, 2:41 PM
`
`Bausch Lomb Inc FDA Filings
`
`PMN K200416 (https://fda.report/PMN/K200416)
`Bausch & Lomb Incorporated
`
`Boston One Step Liquid Enzymatic
`Cleaner
`
`Sodium Chlorode Hypertonicity Ophthalmic
`Solution (https://fda.report/DailyMed/822d25c0-
`71b3-421d-b702-4cded0c4ca32)
`Rugby Laboratories, Bausch & Lomb
`Incorporated
`
`Dorzolamide HCl
`(https://fda.report/DailyMed/8417d162-65a1-
`4266-bca7-707af1193bf3)
`Bausch & Lomb Incorporated
`
`Dexamethasone Sodium Phosphate
`(https://fda.report/DailyMed/6bdcefbe-51e3-
`4ca4-afda-5aeca7b6fa73)
`Bausch & Lomb Incorporated
`
`Prolensa (https://fda.report/DailyMed/4e072537-
`f73c-4a96-a65f-e2805ce112d8)
`Bausch & Lomb Incorporated
`
`Zylet (https://fda.report/DailyMed/3dd9b060-
`5355-404d-bdf1-09ee8b52a9f5)
`Bausch & Lomb Incorporated, Bausch & Lomb
`Incoporated
`
`Prolensa (https://fda.report/DailyMed/4e072537-
`f73c-4a96-a65f-e2805ce112d8)
`Bausch & Lomb Incorporated
`
`Tobramycin and Dexamethasone
`(https://fda.report/DailyMed/33de419e-a89b-
`47e5-952b-87e837f5d531)
`Bausch & Lomb Incorporated
`
`Dorzolamide HCl
`(https://fda.report/DailyMed/8417d162-65a1-
`4266-bca7-707af1193bf3)
`Bausch & Lomb Incorporated
`
`Dorzolamide HCl
`(https://fda.report/DailyMed/8417d162-65a1-
`4266-bca7-707af1193bf3)
`Bausch & Lomb Incorporated
`
`Eye Allergy Relief
`(https://fda.report/DailyMed/873a072f-159b-
`44b8-aad8-33963d961afb)
`Wal-Mart Stores Inc, Bausch & Lomb
`Incorporated, Loba Feinchemie AG
`
`Otc Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Prescription Medication
`
`Prescrip

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket